Growing Therapy Approaches for BRAF-Mutant Advanced Melanoma

Source: Targeted Oncology, February 2022

In an interview with Targeted Oncology, Michael A. Postow, MD, summarized the treatment landscape, provided takeaways from the most recent additions, and discussed other targets for metastatic melanoma.

With both targeted and immunotherapy options, the armory against BRAF-mutant melanoma is well-equipped. As more research is shared, oncologists are continuing to re-shape their practices to achieve the longest possible survival for their patients.

During the Physician’s Education Resource® 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®, Michael A. Postow, MD, presented data around the available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.

READ THE ORIGINAL FULL ARTICLE